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We have investigated in whole cells whether, at low oxygen
concentrations ([O2]), endogenous nitric oxide (NO) modulates the
redox state of the mitochondrial electron transport chain (ETC),
and whether such an action has any signaling consequences. Using
a polarographic-and-spectroscopic-coupled system, we monitored
redox changes in the ETC cytochromes bH, cc1, and aa3 during
cellular respiration. The rate of O2 consumption (VO2) remained
constant until [O2] fell below 15 M, whereas the onset of reduc-
tion of cytochromes aa3, part of the terminal ETC enzyme cyto-
chrome c oxidase, occurred at 50 M O2. Incubation of the cells
with an inhibitor of NO synthase lowered significantly (P < 0.05)
the [O2] at which reduction of the cytochromes occurred. We also
measured intracellular superoxide (O2
) production at different [O2]
and found there was no increase in O2
 generation in control cells,
or those treated with the NO synthase inhibitor, when incubated
at 21% O2. However, after 30-min exposure of control cells to 3%
O2, an increase in O2
 generation was observed, accompanied by
translocation to the nucleus of the transcription factor NF-B. Both
of these responses were diminished by NO synthase inhibition. Our
results suggest that endogenous NO, by enhancing the reduction
of ETC cytochromes, contributes to a mechanism by which cells
maintain their VO2 at low [O2]. This, in turn, favors the release of
O2
, which initiates the transcriptional activation of NF-B as an
early signaling stress response.
The role of nitric oxide (NO) as a signaling molecule involvedin the physiology of the cardiovascular, pulmonary, and
nervous systems has been clearly demonstrated (1). It is widely
accepted that many of the signaling consequences of NO are
mediated through activation of the biochemical target soluble
guanylyl cyclase (2). In the last decade, however, another
potential target has emerged, namely cytochrome c oxidase
(CcO, complex IV), the mitochondrial enzyme responsible for
reduction of O2 into water in the final stage of the electron
transport chain (ETC). NO reversibly inhibits CcO by competing
with O2 for the binuclear binding site (3–5). Moreover, activation
of endothelial NO synthase (NOS) by bradykinin in respiring
endothelial cells results in a decrease in the rate of O2 consump-
tion (VO2), an effect that can be reversed by an inhibitor of NOS
(6). The high affinity of CcO for NO suggests that the nanomolar
concentrations of NO generated in tissues under basal condi-
tions may play a role in the regulation of VO2 (7).
We have recently developed a polarographic-and-spectro-
scopic-coupled system based on visible light spectroscopy (VLS)
to monitor changes in the redox states of the mitochondrial ETC
cytochromes during cellular respiration (8). Using this system,
we have confirmed previous studies showing an early reduction
of cytochrome c at low O2 concentration [O2], without a change
in VO2 (9). This phenomenon has been postulated to be part of
a mechanism to maintain VO2 at decreasing [O2], although there
is no consensus as to the factors that control this process (10, 11).
Increased generation of mitochondrial reactive oxygen species
(ROS) at low [O2] has previously been linked to the activation
of various adaptive signaling pathways (12). However, at present,
the mechanism responsible for the observed increase in ROS at
low [O2] is not clear (see ref. 13 for review). One possibility is
that NO, via its contribution to the early reduction of ETC
cytochromes, favors the generation of ROS. We have therefore
studied the effects of endogenous NO on the ETC redox state in
endothelial and monocytic cells and the subsequent signaling
consequences, specifically the release of ROS and the activation
of NF-B (14).
Materials and Methods
Reagents. Hepes, N-dodecyl--D-maltoside, cytochrome c (from
bovine heart mitochondria), N,N,N,N tetramethyl-p-phenyl-
enediamine, sodium ascorbate, and dihydroethidium (DHE)
were purchased from Sigma; (Z)-1-[2-(2-aminoethyl)-N-(2-
ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NO)
and NG-monomethyl-L-arginine monoacetate (L-NMMA) were
purchased from Alexis (Nottingham, U.K.).
CcO Activity. Experiments with the purified enzyme (from bovine
heart mitochondria) were carried out using the VLS system
described previously (8). Briefly, the sample was placed in an
air-tight respiration chamber (Rank Brothers, Cambridge, U.K.)
maintained at 37°C, in which O2 and NO were measured
polarographically, and emergent light from a broad-band tung-
sten-halogen source was detected in the visible region (490–650
nm). Intensity spectra were converted to changes in optical
attenuation, to which the oxidized-minus-reduced absorption
spectra of mitochondrial cytochromes were fitted using a linear
least-squares algorithm. Changes in cytochrome redox states
were thus monitored simultaneously with [O2] and VO2 every 0.5
seconds.
In the enzyme studies, 1 ml of 20 mM Hepes buffer containing
5l of Intralipid-10% (Pharmacia–Upjohn) at pH 6.8 was placed
in the respiration chamber. Intralipid-10% is an i.v. nutrient
often used in optical studies to simulate the turbidity of cells or
tissue (15). Before closing the chamber, 0.1% dodecyl maltoside,
2 mM sodium ascorbate, 20 M N,N,N,N tetramethyl-p-
phenylenediamine, and 1 M cytochrome c were also added.
Changes in VO2 and the absorption spectra of cytochromes aa3
(from CcO) and c were recorded after the addition of 100 nM
CcO and monitored from the steady-state turnover until full
reduction of the cytochromes, that is, when O2 in the sample was
exhausted (defined as anoxia). The enzyme turnover number
with these concentrations of enzyme and substrates was 15.2 
0.4 electronss1 (n  4).
Abbreviations: ETC, electron transport chain; NOS, NO synthase; CcO, cytochrome c oxidase;
VO2, rate of O2 consumption; VLS, visible light spectroscopy; ROS, reactive oxygen species;
DHE, dihydroethidium; HUVEC, human umbilical venous endothelial cells; RE, reducing
equivalents; DETA-NO, (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-
1,2-diolate; L-NMMA, NG-monomethyl-L-arginine.
§To whom correspondence should be addressed. E-mail: s.moncada@ucl.ac.uk.
© 2004 by The National Academy of Sciences of the USA
7630–7635  PNAS  May 18, 2004  vol. 101  no. 20 www.pnas.orgcgidoi10.1073pnas.0401723101
The O2 dependence of CcO activity was characterized by the
[O2] at which the VO2 decreased to half its maximal value during
the steady-state, termed the P50. Values of the redox state of
cytochromes aa3, denoted Y, were normalized to the total redox
change from the steady-state (Y  1) to the fully reduced form
at anoxia (Y 0). Cytochromes aa3 are not fully oxidized during
turnover, therefore Y  1 does not represent 100% oxidation of
the cytochromes. Indeed, we have previously estimated cyto-
chromes aa3 to be31% reduced during steady-state respiration
in human leukocytes (8). The C50 was defined as the [O2] at
which Y  0.5, i.e., when the cytochrome redox change from the
steady state was 50% of the total.
Experiments with the NO donor DETA-NO were initiated 20
min after its incubation in reaction buffer (without enzyme), at
which time there was a constant release of NO, as detected using
the NO electrode. The concentration of released NO was
determined by measuring the decrease in NO concentration
after the addition of 5 M oxyhemoglobin.
Cells. The murine monocytic cell line RAW 246.7 was purchased
from American Type Culture Collection (Manassas, VA); hu-
man umbilical venous endothelial cells (HUVEC) were pur-
chased from PromoCell (Heidelberg).
HUVEC were grown until passage 4 in phenol red-free
endothelial cell growth medium EGM-1-PRF (PromoCell) in
175-cm2 flasks at 37°C in a 5% CO2humidified air incubator.
Cells were harvested by trypsinization and resuspended in
EGM-1-PRF medium at a concentration of 2–4  107 cells per
ml. The concentration in the medium of the NOS substrate
L-arginine was 300 M. Cell viability was 90%, as determined
by the Trypan blue exclusion method.
RAW 246.7 cells were grown in RPMI medium 1640 supple-
mented with 25 mM Hepes, penicillin–streptomycin (100
unitsml1 and 100 gml1), 2 mM glutamine, and 10% heat-
inactivated New Zealand fetal bovine serum (Life Technologies,
Paisley, U.K.). The cell suspension was maintained by growing
cells in 500-ml stirring bottles in a 5% CO2humidified air
incubator. Cells were harvested by centrifugation at 400  g for
5 min, washed, and resuspended in supplemented phenol red-
free, L-arginine-free RPMI medium 1640 (to which 50 M of
L-arginine was added) at 4–6 107 cells per ml. Cells were used
only when the viability, as measured by Trypan blue, was95%.
Redox Changes in the ETC During Cellular Respiration. Cells were
placed in the respiration chamber of the VLS system to monitor
redox changes in cytochrome bH of complex bc1 (complex III,
cytochrome c reductase), cytochromes aa3 of CcO, and their
shared substrate cytochrome c (in combination with cytochrome
c1 of complex bc1) during cellular respiration to anoxia. We have
previously demonstrated the ability of our system to measure
absolute concentration changes by characterizing the total light
pathlength through the cells (8). In the case of RAW 246.7 cells,
we determined the optical pathlength to be 2.4  0.1 cm (n 
12) in the cell concentration range of interest, allowing the
on-line measurement of absolute cytochrome concentration
changes. In general, however, the redox states of the cyto-
chromes were expressed in terms of the normalized change Y, as
described above for the purified enzyme. This enabled a better
comparison of the O2 dependence of cytochrome redox states in
the two cell lines. As with the isolated enzyme, P50 and C50 are
defined as the [O2] at which cellular VO2 is half-maximal and Y
0.5, respectively.
The term reducing equivalents (RE) is used to describe
components of the ETC in their reduced form. To provide an
indication of the redox state of the ETC at any given [O2], we
have defined RE as the normalized sum of all increases, relative
to the steady-state, in reduced cytochromes, such that 0%
represents the steady-state and 100% the total redox change on
anoxia.
Intracellular Superoxide Production. RAW 246.7 cells at a concen-
tration of 5  107 cells per ml were incubated for 1 h in the
presence or absence of 750 M L-NMMA at 21% O2 (i.e.,
atmospheric conditions) and 37°C. After this time, 10 M DHE
was added to the cell suspensions as a marker of O2
 production;
one-half of each group was maintained at 21% O2; the other half
was transferred to an O2-controlled hypoxic chamber (Coy
Laboratory Products; Ann Arbor, MI) maintained at 3% O2 and
37°C. Cells were agitated gently and aliquots of 5 106 cells were
taken every 15 min and washed with PBS or with 3% O2-
equilibrated PBS, respectively, to remove excess DHE. Cells
were fixed for 10 seconds with 0.5 ml of 70% ethanol on ice and
were then resuspended in 1 ml of normal PBS and analyzed
immediately by flow cytometry (FACSCalibur, Becton Dickin-
son). Data were acquired and analyzed using CELLQUEST soft-
ware (Becton Dickinson). Results are expressed as the mean
fluorescence intensity (MFI).
Activation of NF-B. RAW 246.7 cells at a concentration of 5 107
cells per ml1 were incubated for 30 min in the presence or
absence of 750 M L-NMMA at 21% O2 and 37°C. A sample
from each group was kept in these conditions, and the rest was
transferred to the hypoxic chamber maintained at 3% O2 and
37°C. Aliquots were taken every 15 min for determination of
NF-B translocation to the nucleus. The first step of nuclear
extraction from the cells kept at 3% O2 was carried out inside the
hypoxic chamber to avoid the effect of cellular reoxygenation.
Aliquots of 1.25  107 cells per ml were washed in ice-cold
O2-equilibrated PBS with phosphatase inhibitors, and nuclear
extraction was carried out according to the manufacturer’s
instructions (nuclear extract kit, Active Motif Europe, Rixensart,
Belgium). Protein content in the nuclear extract was determined
to adjust the amount to 30 g per well for each sample. Samples
of 30 g of protein were analyzed by Western blotting using a
rabbit polyclonal antibody (Biomol Research Laboratories, Ply-
mouth Meeting, PA) against NF-B (p65 subunit) followed by an
anti-rabbit horseradish peroxidase conjugate (Vector Labora-
tories). The protein band was detected by enhanced chemilumi-
nescence (Amersham Pharmacia).
Measurement of Intercellular PO2. Measurements of the partial
pressure of O2 (PO2) in a cell suspension open to the environ-
ment were carried out by using an O2 probe based on O2
quenching of fluorescence (OxyLite, Oxford Optronics, Oxford,
U.K.). The sensor was used to measure the PO2 in the medium
of cell suspensions exposed either to 21% (atmospheric) or 3%
(hypoxic chamber) O2, in a shaking water bath maintained at
37°C. Measurements of PO2 were converted to [O2] in M,
taking into account the salinity and temperature of the medium
and daily atmospheric and water vapor pressure (16).
Statistical Analysis. Means standard deviations were calculated
for quantitative analysis of the results. Statistically significant
differences (P  0.05) between samples were determined using
Student’s paired t test.
Results
Effect of Exogenous NO on the Redox State of Purified CcO. Studies
of the redox changes (Y) in purified CcO in turnover showed that
increasing concentrations of NO led to a progressive increase in
C50 (see Fig. 1), with an equivalent effect on P50. Table 1
summarizes these parameters for given concentrations of
DETA-NO (the NO donor). NO also caused a progressive
increase in the [O2] at which the reduction of cytochromes aa3








occurred; at the concentrations of NO used, the change in Y was
linearly related to the decrease in VO2.
Effect of Endogenous NO on Cellular Respiration. The on-line time
course of [O2] and VO2 was monitored in RAW 246.7 cells at a
concentration of 5.3  1.4  107 cells per ml (n  12). The
maximum VO2 during steady-state respiration was 56.2  9.7
Mmin1; this was maintained until [O2] decreased to 15 M
(see Fig. 2A). The corresponding changes in the redox states of
cytochromes bH, cc1, and aa3 in terms of absolute concentration
changes (i.e., corrected for the optical pathlength) were also
monitored (Fig. 2B). An early reduction of cytochromes aa3 and
cc1 occurred at an [O2], at which VO2 was still maximal (see Fig.
2A). This is also shown in Fig. 2C, in which VO2 and Y are plotted
against [O2]. In contrast, the redox state of cytochrome bH was
maintained in its steady-state until the [O2] was 10 M.
To determine whether basal concentrations of NO in intact
cells modulate the O2 dependence of the redox state of cyto-
chromes aa3, as observed in purified CcO, we compared cellular
respiratory parameters in the presence and absence of the NOS
inhibitor L-NMMA. Table 2 summarizes values of C50 and P50 in
RAW 246.7 cells and HUVEC, with and without L-NMMA. The
P50 was significantly (P  0.05) decreased in both cell types by
treatment with L-NMMA. Values of C50 were also significantly
(P  0.05) decreased in the presence of the NOS inhibitor.
Effect of Endogenous NO on Formation of RE in the ETC. Fig. 3 shows
the increase in RE with decreasing [O2] in RAW 246.7 cells and
HUVEC, respectively, in the absence and presence of L-NMMA.
Above 50 M O2, the redox state of the ETC cytochromes was
independent of [O2], and there was no difference in RE between
control and L-NMMA-treated cells. As [O2] decreased below 50
M, the presence of basal concentrations of NO in control cells
led to a more pronounced increase in RE at any given [O2]
compared to L-NMMA-treated cells. For example, a 10% in-
crease in RE from the steady-state occurred at an [O2] of 20.2
6.2 and 22.6  7.6 M (n  6) in control RAW 246.7 cells and
HUVEC, respectively. This occurred at significantly (P  0.05)
lower [O2] in L-NMMA-treated cells, with values of 15.7  5.5
and 15.0  3.8 M, respectively (Fig. 3). In both control and
L-NMMA-treated cells, the VO2 was still maximal at the [O2] at
which RE had increased by 10%. At the [O2] at which a 10%
decrease in VO2 was observed (11.9  2.3 M in control RAW
246.7 cells and 13.6  5.7 M in control HUVEC), the increase
in RE was 20.1  4.6 and 21.9  4.3%, respectively.
Effect of Endogenous NO on the Release of O2
 and Nuclear Migration
of NF-B. The production of O2
 was studied in RAW 246.7 cells
incubated at 21% O2 for 1 h in the presence or absence of
L-NMMA. DHE was then added to the cells; one-half of each
group was maintained at 21% O2 and the other half at 3% O2.
[O2] values of 62 and 4 M were measured in the medium of cells
(4  107 cells per ml) incubated at 21% and 3% O2, respec-
tively.
Fig. 4A shows that there was no significant difference in DHE
fluorescence in cells incubated for 30 min at 21% O2 in the
presence or absence of L-NMMA, with a MFI of 3.3  0.7 and
3.0  0.6 (n  3) for control and L-NMMA-treated cells,
respectively. When cells were incubated for 30 min at 3% O2 (see
Fig. 4B), there was a significant (P  0.05) increase in fluores-
cence in control but not in L-NMMA-treated cells (MFI of 7.2
0.9 and 3.9  1.3, respectively).
To study the downstream consequences of this increase in O2
,
we analyzed the time course of NF-B migration to the nucleus
in the same system. Fig. 4C shows the absence of NF-B in the
nuclear extracts of cells exposed to 21% O2, both with and
without L-NMMA. When the cells were incubated in the hypoxic
chamber at 3% O2, however, there was a large time-dependent
increase of NF-B in control cells that was diminished by
treatment with L-NMMA.
Discussion
The finding that NO inhibits CcO in a manner that is competitive
with O2 and reversible led to the concept that NO might regulate
mitochondrial VO2. Because the potency of NO increases as the
[O2] decreases, it is likely that the low concentrations of NO
found in tissues (17) may, under certain conditions, successfully
compete with O2 for the binuclear binding site of CcO (4, 18).
The nature of the interaction between NO and purified CcO or
isolated mitochondria has now been extensively studied (for
reviews, see refs. 19 and 20). However, a role for endogenous NO
in the regulation of VO2 remains to be fully understood, and so
far only a few studies have demonstrated that basal concentra-
tions of endogenous NO are able to modulate respiration
physiologically both in vitro and in vivo (6, 21, 22).
Using our recently developed VLS system, we have previously
demonstrated in whole cells that exogenously applied NO causes
a reversible inhibition of VO2, with a concomitant decrease in
the redox state of cytochromes aa3 and consequently, the
upstream cytochromes cc1 and bH (8). We have now used this
system to study the effects of NO on the activity and redox
behavior of purified CcO at a relatively low turnover (15
electronss1) and have confirmed the well-known increase in
the apparent Km for O2 (4). Furthermore, at concentrations at
which NO inhibited VO2, we found a progressive increase in the
[O2] at which the onset of reduction of cytochromes occurred.
Fig. 1. Effect of exogenous NO on the redox state of purified CcO. Normal-
ized changes in the redox state of cytochromes aa3 from the steady state (Y
1) to anoxia (Y 0) against [O2] for 100 nM of purified CcO in turnover (solid
black line) and the effect of exogenous NO administered as 50 M (solid gray
line) and 200 M (dotted black line) DETA-NO.
Table 1. Effect of exogenous NO on purified CcO enzyme
in turnover
DETA-NO, M NO, nM C50, M P50, M
0 0 2.8  0.3 2.8  0.5
50 118  19 5.3  1.1 5.0  0.7
200 470  27 29.0  10.0 30.5  11.0
Values of [O2] for which VO2 and the change in the redox state of cyto-
chromes aa3 are half-maximal (P50 and C50, respectively), obtained from pu-
rified CcO in turnover measured using the VLS system (n 3). The concentra-
tion of NO released from the donor DETA-NO was determined by the decrease
in NO measured by the NO electrode after the addition of 5 M oxyhemo-
globin (n  3).
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In respiring cells, however, we observed an early reduction in
cytochromes aa3 and cc1 relative to the decrease in VO2. We and
others have previously reported this early reduction of cyto-
chromes in cells (8, 9), and other authors have described it in vivo
(23). Although the nature and biological significance of this
phenomenon remain controversial (9, 24), one interesting sug-
gestion is that the early reduction of mitochondrial cytochromes
may be a manifestation of a mechanism by which cells maintain
their respiratory rate at low [O2]. Our results with L-NMMA
indicate that such a mechanism may be partly attributable to
endogenous NO. This is supported by the observation that in
yeast, in which the effects of NO are abolished by the scavenging
action of a constitutive flavohemoglobin protein (25), no early
reduction of the cytochromes occurs (24). Interestingly, we did
not observe an early reduction in cytochrome bH. Although the
explanation for this phenomenon is not clear, it is possible that
it could be due in part to a difference in midpoint potentials of




 is generated by the interaction between O2
and RE, and thus the rate of its formation in any given situation will
depend on the concentrations of these two reactants (13). Under
atmospheric conditions, high concentrations of exogenous NO have
been shown to produce O2
 and H2O2 in submitochondrial particles,
rat heart mitochondria (26), and Langendorf preparations of
isolated hearts (27). Furthermore, we have previously shown that
treatment of human lymphoid T cells with a proapoptotic stimulus
(anti-Fas Ab) leads to an increase in O2
 generation that depends
on endogenous NO (28). All these experiments, however, were
carried out at high [O2], unlike those found in vivo.
As the [O2] decreases, it is likely that there will be a point at
which the increase in RE resulting from a more potent interac-
tion between NO and CcO compensates for the decreased
availability of O2, thus creating a favorable situation for the
formation of O2
. Our results showing an increase in intracellular
generation of O2
 at low [O2] compared with atmospheric
conditions confirm this and are in agreement with the reports of
others (14, 29, 30). As expected, we found that O2
 production
was significantly diminished by treatment with L-NMMA.
Fig. 2. Cellular respiration and changes in the mitochondrial cytochrome redox states monitored by VLS. RAW 246.7 cells were placed in a closed respiration
chamber and allowed to consume O2 until anoxia. (A) On-line recording of changes in [O2] (solid black line) and VO2 (dotted gray line) against time using the
VLS system. (B) On-line recording of changes in concentration of cytochromes bH (filled circles), cc1 (filled triangles), and aa3 (open squares) from the steady-state
against time. Negative values indicate an increase in reduced and a decrease in oxidized cytochromes and vice versa. (C) Changes in VO2 (dotted gray line),
normalized between 1 and 0, and Y, the normalized changes in cytochrome redox states for cytochromes bH (filled circles), cc1 (filled triangles), and aa3 (open
squares), against [O2].
Table 2. Effect of endogenous NO on cellular respiration and
cytochrome redox states
Cell type L-NMMA [Cell] (107 cells per ml) C50, M P50, M
RAW 246.7  5.3  1.0 8.3  3.0 6.1  2.7
	 5.2  1.7 4.9  2.6 2.9  1.7
HUVEC  2.9  0.4 10.8  5.6 8.1  4.3
	 3.1  0.7 5.6  3.1 4.1  2.8
Values of [O2] for which VO2 and the change in the redox state of cyto-
chromes aa3 are half-maximal (P50 and C50, respectively), obtained from intact
cells (RAW 246.7 and HUVEC) during respiration measured using the VLS
system (n  6) in the absence () and presence (	) of the NOS inhibitor
L-NMMA.








Mitochondrial production of ROS has been linked to the
translocation of NF-B to the nucleus as a hypoxic stress
signaling response (14). Our experiments clearly show that NO
is involved in this process, because the increase in mitochon-
drial RE, the generation of mitochondrial O2
, and the acti-
vation of NF-B were all closely correlated and could be
attenuated by treatment with L-NMMA. Interestingly, this
mechanism appears to be activated at [O2] well above those
that are critical for the maintenance of steady-state cellular
respiration and also at concentrations of NO below those at
which this gas inhibits respiration. Thus the generation of O2

and the translocation of NF-B might not, strictly speaking, be
a cellular response to hypoxia. Although decreasing [O2] may
be one of the triggers, any factors that enhance interaction
Fig. 3. Effect of endogenous NO on the increase in RE in the ETC at low [O2]. Increases in RE in the ETC are represented by the normalized sum of changes in
the cytochrome redox states. Dotted lines indicate a 10% increase in RE and the corresponding [O2] (significantly different, P 0.05, with and without L-NMMA).
Data are the mean of six experiments. (A) Changes in RE against [O2] for RAW 246.7 cells in the absence (filled circles) or presence (open circles) of 750M L-NMMA.
(B) Changes in RE against [O2] for HUVEC in the absence (filled triangles) or presence (open triangles) of 500 M L-NMMA. Broken lines show the [O2] at which
there is a 10% increase in RE.
Fig. 4. Effect of endogenous NO on the production of O2
 and nuclear migration of NF-B at different [O2]. (A) Fluorescence, as measured by flow cytometry
from intact cells incubated with DHE for 30 min, indicating intracellular O2
 production in the presence (shaded) or absence (clear) of L-NMMA at 21% O2. (B)
Fluorescence, as described in A, indicating intracellular O2
production in the presence (shaded) or absence (clear) of L-NMMA at 3% O2 (C) Western blot of nuclear
extracts of cells incubated at 21 and 3% O2 detecting NF-B (p65 subunit) in the absence () or presence (	) of L-NMMA at 30 and 60 min.
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between NO and CcO, leading to an increase in RE, could
result in the activation of this signaling cascade, even at high
[O2]. Our results thus provide a clearer understanding of the
role of NO in this ‘‘early warning’’ system, in which a change
in the mitochondrial ETC redox state triggers a nuclear
mechanism for cellular defense.
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